Floatz logo

Therapeutic Asset Ratings

329 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
bi 3006337
Obesity Disorder
Boehringer IngelheimP1C (39)
bi 456906
Obesity
Boehringer IngelheimP1C (39)
DEXKETOPROFEN
Obesity
Kirsehir Ahi Evran UniversitesiP1C (39)
Ent-03
Obesity Disorder
Metabolics PharmaP1C (39)
GLUCAGON-LIKE PEPTIDE 1, HUMAN
Obesity Disorder
Indiana UniversityP1C (39)
Glucose-Dependent Insulinotropic Polypeptide
Obesity Disorder
Novo Nordisk A/SP1C (39)
hec88473
Obesity Disorder
Dongguan HEC Biopharmaceutical R&D Co., Ltd.P1C (39)
Insulin Human
Obesity Disorder
Columbia UniversityP1C (39)
METAMIZOLE
Obesity
Kirsehir Ahi Evran UniversitesiP1C (39)
Monlunabant
Obesity Disorder
Novo Nordisk A/SP1C (39)
pf-06954522
Obesity Disorder
PfizerP1C (39)
RIFALDAZINE
Obesity
Vincentage Pharma Co., LtdP1C (39)
t2026
Obesity Disorder
Sciwind Biosciences APAC CO Pty. Ltd.P1C (39)
1-235-TUMOR NECROSIS FACTOR RECEPTOR (HUMAN) FUSION PROTEIN WITH 236-467-IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN FC FRAGMENT), DIMER
Obesity Disorder
Duke UniversityP1C (36)
Abbv-295
Obesity Disorder
AbbVieP1C (36)
aciclovir
Obesity Disorder
University Hospital, ToulouseP1C (36)
Aln-6222
Obesity Disorder
Alnylam PharmaceuticalsP1C (36)
azd1043
Obesity Disorder
AstraZenecaP1C (36)
Bmf-650
Obesity Disorder
Biomea Fusion Inc.P1C (36)
Brenipatide
Obesity Disorder
Eli Lilly and CompanyP1C (36)
da-1726
Obesity Disorder
NeuroBo Pharmaceuticals Inc.P1C (36)
DEXTROSE SOLUTION
Obesity Disorder
Columbia UniversityP1C (36)
Firategrast
Obesity
Boehringer IngelheimP1C (36)
Follicle Stimulating Hormone
Obesity Disorder
University of Colorado, DenverP1C (36)
hm17321
Obesity Disorder
Hanmi Pharmaceutical Company LimitedP1C (36)
Showing 226 to 250 of 329 assets
PreviousPage 10 of 14Next